Panel Contributors
All samples and data were collected with informed consent under local IRB approved protocols. These samples are generously shared by Drs. A. Gregory Sorensen, Karen Furie, Michael S. Okun, Ronald Mandel, David Simon, John Hardy, David Coffey, Russell Buono, Micheline Gravel, Robert Hamill, Ray Watts, and Rodger Elble. Brief Description
This panel contains 5 micrograms of DNA/well from 92 unique and unrelated White individuals without neurological disorders. Of these, 50 are males and 42 are females, with an age range of 55-84 years. All are from the continental United States. Four wells remain empty for additional laboratory controls. The difference between NDPT079 and the panel it replaces, NDPT009, is that ND07302 (on NDPT079) replaces ND05016 (which was on NDPT009).
Data collected on these subjects consisted of Control Clinical Data Elements as outlined in the Coriell NINDS Repository website (http://ccr.coriell.org/Sections/Collections/NINDS/ClinicalDataForms.aspx?PgId=148&coll=ND). These data elements were developed in order to be consistent with other NIH healthy control sample collections including that of the National Institute on Aging Late Onset Alzheimer's Disease Consortium (LOAD). These data include a detailed medical and family history, and in many cases a neurological examination and Folstein Mini-Mental Status examination score.
Briefly, all underwent a detailed medical history interview. None have a history of neurological illness in themselves. All were asked specifically regarding the following disorders, which were reported as not present: Alzheimer's, amyotrophic lateral sclerosis, ataxia, autism, bipolar disorder, brain aneurysm, dementia, dystonia, and Parkinson Disease. Reported Folstein Mini-mental examination scores ranged from 26-30 - 30/30.
All were interviewed for family history in detail. None reported a family history of any first degree relative when asked about the following disorders: amyotrophic lateral sclerosis, ataxia, autism, brain aneurysm, dystonia, Parkinson Disease, schizophrenia.
Publications
Please cite the panel number and the NINDS repository in any publications, as well as the catalog number of individual samples that are of particular interest, and share those references with the NINDS Repository Management Team at Coriell (NINDS@Coriell.org). Portions or all of this statement may be used in publications relevant to this panel.
Other Healthy controls, Positive controls
Additional control samples from individuals without neurological disease themselves, and with a range of clinical data, is available via the NINDS Repository catalog. Single samples from this panel can also be obtained, individually. Positive control samples for known causal genes are available, as listed, under specific disorders which may be useful as controls for this panel are additionally available via the NINDS Repository catalog.